Idexx Laboratories (IDXX) Income towards Parent Company: 2009-2025
Historic Income towards Parent Company for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $274.6 million.
- Idexx Laboratories' Income towards Parent Company rose 17.94% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.61%. This contributed to the annual value of $887.9 million for FY2024, which is 5.07% up from last year.
- Latest data reveals that Idexx Laboratories reported Income towards Parent Company of $274.6 million as of Q3 2025, which was down 6.59% from $294.0 million recorded in Q2 2025.
- Idexx Laboratories' 5-year Income towards Parent Company high stood at $294.0 million for Q2 2025, and its period low was $132.0 million during Q2 2022.
- For the 3-year period, Idexx Laboratories' Income towards Parent Company averaged around $231.3 million, with its median value being $224.2 million (2023).
- Its Income towards Parent Company has fluctuated over the past 5 years, first surged by 82.60% in 2021, then plummeted by 34.61% in 2022.
- Quarterly analysis of 5 years shows Idexx Laboratories' Income towards Parent Company stood at $162.8 million in 2021, then rose by 5.80% to $172.2 million in 2022, then climbed by 12.96% to $194.5 million in 2023, then increased by 11.12% to $216.1 million in 2024, then rose by 17.94% to $274.6 million in 2025.
- Its Income towards Parent Company was $274.6 million in Q3 2025, compared to $294.0 million in Q2 2025 and $242.7 million in Q1 2025.